《重症患者应激性溃疡预防与治疗指南(2026)》
应激性溃疡是重症患者常见并发症,与死亡风险增加和 ICU 住院时间延长相关。近年多项关于危险因素、预防与治疗的大规模临床研究为新指南提供了证据,且临床实践中缺乏标准化方案。中国重症医学学会组建多学科专家组,按 GRADE 方法经过提出临床问题、文献检索与筛选、Meta 分析与证据合成、推荐条目初拟、专家组评审、三轮远程会议、四轮面对面会议、稿件修订及学会常务委员会最终批准,制定《重症患者应激性溃疡预防与治疗指南(2026)》,以 23 条证据推荐定稿,覆盖危险因素、预防、治疗及抑酸药物不良反应等关键方面,旨在为成人重症患者应激性溃疡的规范化管理提供循证指导。
要点
- 指南由中华医学会重症医学分会(Chinese Society of Critical Care Medicine)组建多学科专家组制定,采用 GRADE 方法,最终形成 23 条证据推荐。
- 推荐内容覆盖重症成人应激性溃疡的危险因素、预防、治疗以及抑酸药物的不良反应四个关键方面。
- 指南制定过程包括提出临床问题、文献检索与筛选、Meta 分析与证据合成、推荐条目初拟、专家组评审、三轮远程会议、四轮面对面会议及学会常务委员会批准。
- 应激性溃疡与重症患者死亡风险增加和 ICU 住院时间延长相关,临床实践缺乏标准化防治方案是指南制定的背景。
- 指南以成人重症患者为管理对象,旨在为医疗专业人员提供循证指导并促进应激性溃疡的规范化临床管理。
适用人群与场景
- 成人重症患者,适用于应激性溃疡的预防与治疗管理。
研究设计与关键结果
- 中国重症医学学会组建多学科专家组,按 GRADE 方法制定《重症患者应激性溃疡预防与治疗指南(2026)》,最终以 23 条证据推荐定稿。
- 制定过程包括提出临床问题、文献检索与筛选、Meta 分析与证据合成、推荐条目初拟、专家组评审、三轮远程会议、四轮面对面会议、稿件修订及学会常务委员会最终批准。
- 指南覆盖危险因素、预防、治疗及抑酸药物不良反应等关键方面,旨在为成人重症患者应激性溃疡提供循证指导并促进规范化管理。
证据类型、等级与局限
- 证据类型:指南,采用 GRADE(推荐分级的评估、制定与评价)方法制定。
- 推荐数量:23 条证据推荐。
- 制定机构:中国重症医学学会(Chinese Society of Critical Care Medicine)。
- 局限:原文未报告局限性
对床旁实践的改变
- 指南针对临床实践中应激性溃疡防治缺乏标准化方案、管理策略不一致的问题,提供基于证据的规范化指导。
- 指南适用于成人重症患者应激性溃疡的危险因素评估、预防、治疗及抑酸药物不良反应管理。
指南或共识出处
- Guidelines for the prevention and treatment of stress ulcers in critically ill patients (2026),中国重症医学学会(Chinese Society of Critical Care Medicine)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Stress ulceration is a common complication in critically ill patients, associated with increased mortality risk and prolonged intensive care unit (ICU) stay. In recent years, several large-scale clinical studies on risk factors, prevention, and treatment of stress ulcers have provided new evidence for guideline development. Moreover, the lack of standardized protocols for the prevention and treatment of stress ulcers in clinical practice underscores the urgent need for authoritative guidelines to address current inconsistencies in management strategies. Accordingly, the Chinese Society of Critical Care Medicine established a multidisciplinary expert panel to develop the Guidelines for the prevention and treatment of stress ulcers in critically ill patients (2026). Following the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology, the guideline formulation process involved proposing clinical questions, literature retrieval and screening, meta-analysis and evidence synthesis, initial formation of recommendation items, panel reviews, three rounds of remote meetings, four rounds of face-to-face meetings, manuscript revisions, and final approval by the Standing Committee of the Society. The guidelines were finalized in the form of 23 evidence-based recommendations. These guidelines cover key aspects of stress ulcer management, including risk factors, prevention, treatment, and adverse effects of acid-suppressive drugs. The aim is to provide evidence-based guidance for healthcare professionals and promote standardized clinical management of stress ulcers in adult patients.
参考来源
- The Stress Ulcer Prevention and Treatment Guideline Development Group of the Chinese Society of Critical Care Medicine, Chinese Medical Association. [Guidelines for the prevention and treatment of stress ulcers in critically ill patients (2026)]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2026. PMID: 41833343. doi:10.3760/cma.j.cn121430-20251203-00583
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。